<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03722771</url>
  </required_header>
  <id_info>
    <org_study_id>106</org_study_id>
    <nct_id>NCT03722771</nct_id>
  </id_info>
  <brief_title>Influence of Lavender Oil on Vital Signs in Oral Surgery Patients</brief_title>
  <official_title>Influence of Lavender Oil on Vital Signs and Anxiety in Oral Surgery Patients: a Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nazife Begüm KARAN</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Recep Tayyip Erdogan University Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the impact of lavender oil (Lavandula angustifolia)
      on anxiety, mood, vital signs (blood pressure, respiratory rate, heart rate and saturation)
      for oral surgery patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lavender oil has sedative properties. Oral surgical procedures have been proven as to be the
      greatest concern among dental practices for patients. Limited randomized clinical trials have
      demonstrated evidence-based results of lavender oil, despite being the most effective
      essential oil for anxiety and stress. The hypothesis of the present study was that the
      inhalation of lavender oil prior to oral surgical procedures may reduce anxiety and
      consequently may effect intra and post-operative blood pressure, inspiration and heart rate.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Actual">November 2, 2018</completion_date>
  <primary_completion_date type="Actual">November 2, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vital Sign Measurements - 1 - changes in blood pressure</measure>
    <time_frame>through study completion an average of 3 months</time_frame>
    <description>changes in blood pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vital Sign Measurements - 2 - changes in respiratory rate</measure>
    <time_frame>through study completion an average of 3 months</time_frame>
    <description>changes in respiratory rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vital Sign Measurements - 3 - changes in heart rate</measure>
    <time_frame>through study completion an average of 3 months</time_frame>
    <description>changes in heart rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vital Sign Measurements - 4 - changes in saturation level</measure>
    <time_frame>through study completion an average of 3 months</time_frame>
    <description>changes in saturation level</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anxiety Test 1 - MDAS tests</measure>
    <time_frame>through study completion an average of 3 months</time_frame>
    <description>MDAS tests</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety Test 2 - STAI-S tests</measure>
    <time_frame>through study completion an average of 3 months</time_frame>
    <description>STAI-S tests</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">126</enrollment>
  <condition>Dental Anxiety</condition>
  <condition>Sedative; Anxiety Disorder</condition>
  <arm_group>
    <arm_group_label>lavender oil group (A)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100 % pure, high strength lavender oil inhalation in a separate room for 3 minutes, prior to surgery.
Anxiety questionnaires 1 (MDAS) Anxiety questionnaires 2 (STAI-S) Vital signs 1 (Blood pressure) Vital signs 2 (respiratory rate,) Vital signs 3 (heart rate) Vital signs 4 (saturation)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group (B)</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>No application of lavender oil, prior to surgery. Anxiety questionnaires 1 (MDAS) Anxiety questionnaires 2 (STAI-S) Vital signs 1 (Blood pressure) Vital signs 2 (respiratory rate,) Vital signs 3 (heart rate) Vital signs 4 (saturation)</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Inhalation</intervention_name>
    <description>lavender oil inhalation in a separate room for 3 minutes prior to surgery</description>
    <arm_group_label>lavender oil group (A)</arm_group_label>
    <other_name>lavender oil application</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Anxiety Questionnaires 1</intervention_name>
    <description>Modified Dental Anxiety Scale was used to describe the level of the dental anxiety.</description>
    <arm_group_label>control group (B)</arm_group_label>
    <arm_group_label>lavender oil group (A)</arm_group_label>
    <other_name>Modified Dental Anxiety Scale</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Anxiety Questionnaires 2</intervention_name>
    <description>State-Trait Anxiety Inventory-State Scale was used to distinguish the true anxiety level of the patients from the anxiety level for a particular situation.</description>
    <arm_group_label>control group (B)</arm_group_label>
    <arm_group_label>lavender oil group (A)</arm_group_label>
    <other_name>State-Trait Anxiety Inventory-State Scale</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Vital Signs 1</intervention_name>
    <description>Changes in vital signs 1 - blood pressure - before, during and after the procedure were noted.</description>
    <arm_group_label>control group (B)</arm_group_label>
    <arm_group_label>lavender oil group (A)</arm_group_label>
    <other_name>Blood Pressure</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Vital Signs 2</intervention_name>
    <description>Changes in vital signs 2 - respiratory rate - before, during and after the procedure were noted.</description>
    <arm_group_label>control group (B)</arm_group_label>
    <arm_group_label>lavender oil group (A)</arm_group_label>
    <other_name>Respiratory rate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Vital Signs 3</intervention_name>
    <description>Changes in vital signs 3 - heart rate - before, during and after the procedure were noted.</description>
    <arm_group_label>control group (B)</arm_group_label>
    <arm_group_label>lavender oil group (A)</arm_group_label>
    <other_name>Heart rate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Vital Signs 4</intervention_name>
    <description>Changes in vital signs 4 - saturation - before, during and after the procedure were noted.</description>
    <arm_group_label>control group (B)</arm_group_label>
    <arm_group_label>lavender oil group (A)</arm_group_label>
    <other_name>Saturation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of wisdom tooth

          -  Must be similar in age-height-weight

          -  Must be similar socio-culturally

        Exclusion Criteria:

          -  Under 18 years of age

          -  Taking psychotropic medication or psychiatric treatment

          -  Systemically unhealthy patients

          -  Pregnants
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>37 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nazife Begüm KARAN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Recep Tayyip Erdogan University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nazife Begüm KARAN</name>
      <address>
        <city>Ri̇ze</city>
        <state>Merkez</state>
        <zip>053100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>October 22, 2018</study_first_submitted>
  <study_first_submitted_qc>October 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2018</study_first_posted>
  <last_update_submitted>June 9, 2020</last_update_submitted>
  <last_update_submitted_qc>June 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Recep Tayyip Erdogan University Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Nazife Begüm KARAN</investigator_full_name>
    <investigator_title>Assistant Professor, DDS, PhD</investigator_title>
  </responsible_party>
  <keyword>Lavandula</keyword>
  <keyword>phytotherapy</keyword>
  <keyword>aromatherapy</keyword>
  <keyword>dental anxiety</keyword>
  <keyword>anaesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

